This cyber security stock is clawing back gains after a week of losses, making it a top mover in the portfolio Monday

Eli Lilly CEO, David Ricks discussed the company's positive results from its latest Alzheimer's study. While LLY is a direct play into treating the disease, we have another stock that will also benefit from Alzheimer's treatments on the infrastructure side of the health care business.